Immunic, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 25.27 million compared to USD 20.81 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 0.74 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | +1.64% | -0.80% | -17.33% |
05-08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.33% | 110M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023